Trial | NCT00703183  Report issue

Title

Safety and Tolerability of ACU-4429
A Single Center, Randomized, Double-Masked, Dose-Escalating, Placebo-Controlled Study of the Safety and Tolerability ACU-4429 in Healthy Volunteers

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    emixustat ...

  • Study Participants

    46
The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.
Study Started
May 31
2008
Primary Completion
Jun 30
2009
Study Completion
Jun 30
2009
Last Update
Jun 27
2012
Estimate

Drug matching placebo

administered as a single dose, orally

Drug ACU-4429

administered as a single dose, orally

1 Experimental

ACU-4429

2 Placebo Comparator

matching placebo

Criteria 

Inclusion Criteria:

Is male or female with age ≥ 55 and ≤ 80 years at the time of consent
Is healthy as determined by medical history and physical examination

Exclusion Criteria:

Is receiving or has recently received treatment with a medication disallowed per the protocol
No Results Posted